CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-16 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −53,489 | $91.06 | $4.9M | 117,560 |
| 2024-04-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −4,305 | $92.67 | $399K | 230,221 |
| 2024-04-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,411 | $93.91 | $226K | 227,810 |
| 2024-04-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −100 | $94.44 | $9K | 227,710 |
| 2024-04-03 | Sheena Jonathan Director | Sale 10b5-1 | −8,699 | $91.53 | $796K | 339,032 |
| 2024-04-03 | Sheena Jonathan Director | Sale 10b5-1 | −10,138 | $92.57 | $938K | 328,894 |
| 2024-04-03 | Sheena Jonathan Director | Sale 10b5-1 | −7,863 | $93.37 | $734K | 321,031 |
| 2024-04-02 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,378 | $92.62 | $128K | 70,646 |
| 2024-03-28 | Sheena Jonathan Director | Sale 10b5-1 | −134 | $90.42 | $12K | 348,044 |
| 2024-03-28 | Sheena Jonathan Director | Sale 10b5-1 | −313 | $90.13 | $28K | 347,731 |
| 2024-03-28 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $90.13 | $45K | 69,582 |
| 2024-03-28 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $90.13 | $45K | 69,582 |
| 2024-03-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −743 | $90.42 | $67K | 204,839 |
| 2024-03-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −707 | $90.42 | $64K | 197,560 |
| 2024-03-28 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −464 | $90.42 | $42K | 112,199 |
| 2024-03-28 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,662 | $90.42 | $241K | 234,526 |
| 2024-03-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −914 | $90.42 | $83K | 72,024 |
| 2024-03-27 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +447 | 348,178 | ||
| 2024-03-27 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −447 | 0 | ||
| 2024-03-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +1,364 | 205,582 |
Page 75 of 85 · 1,682 trades